EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

A comparison of antiplatelet and oral anticoagulation strategies to prevent cerebral microembolism after transcatheter aortic valve implantation: the AUREA trial

Victor Alfonso Jimenez Diaz, Pablo Juan-Salvadores, Paula Bellas Lamas, Mercedes Arias Gonzalez, Eloisa Santos Armentia, Oscar Vila Nieto, Carmen Gonzalez Mao, Tamara Torrado Chedas, Antonio Jesus Muñoz Garcia, Ivan Gomez Blazquez, Guillermo Bastos Fernandez, Antonio De Miguel Castro und 12 weitere

EuroIntervention · 2025

DOI: 10.4244/eij-d-24-00872 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2025. Verfasst von Victor Alfonso Jimenez Diaz und 23 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Álvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Platelet Aggregation Inhibitors, Intracranial Embolism, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The effectiveness of oral anticoagulation (OAC) or dual antiplatelet therapy (DAPT) in reducing subclinical brain infarcts after transcatheter aortic valve implantation (TAVI) remains unclear. AIMS: We aimed to compare the efficacy of DAPT versus OAC in preventing cerebral microembolism during the first 3 months post-TAVI, assessed by diffusion-weighted magnetic resonance imaging (DW-MRI). METHODS: Patients with aortic stenosis and no indication for OAC were randomly assigned to receive either OAC (acenocoumarol) or DAPT (aspirin+clopidogrel) for 3 months post-TAVI. Brain DW-MRI was performed at baseline (0-3 days pre-TAVI) and at 6 and 90 days post-TAVI. The primary objective was the proportion of patients with new cerebral emboli on DW-MRI at 6 and 90 days. RESULTS: Of the 123 patients included in the study, 3.3% had new cerebral emboli on the baseline MRI prior to TAVI. At 6 days post-TAVI, new cerebral emboli were observed in 81.4% of OAC patients versus 69.8% of DAPT patients (p=0.209), and at 90 days, in 8.0% versus 8.2%, respectively (p=0.879). However, DAPT patients had a lower mean total emboli volume at 6 days (265.9 mm³ vs 303.4 mm³; p=0.019) and cumulatively at 6+90 days (266.45 mm³ vs 331.10 mm³; p=0.008). CONCLUSIONS: In patients without an indication for OAC, an OAC strategy for 3 months post-TAVI did not show any benefit over an antiplatelet strategy in preventing cerebral microembolism. Patients treated with DAPT showed a lower mean volume of brain damage on DW-MRI during the 90 days following TAVI compared to those treated with acenocoumarol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementPlatelet Aggregation InhibitorsIntracranial EmbolismAnticoagulantsAortic Valve StenosisHumansMaleFemaleAged, 80 and overAgedAdministration, OralDiffusion Magnetic Resonance ImagingTreatment OutcomeAspirinClopidogrelAcenocoumarol

Substanzen

Platelet Aggregation InhibitorsAnticoagulantsAspirinClopidogrelAcenocoumarol

Autor:innen und Institutionen

  • Cardiology Department, Hospital Álvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain.
  • Cardiovascular Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
  • Neurology Department, Hospital Álvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain.
  • Diagnostic Imaging Unit, Galaria, Public Sanitary Services Company, Vigo, Spain.
  • Radiology Department, Hospital Ribera Povisa, Vigo, Spain.
  • Diagnostic Imaging Department, Hospital Álvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain.

Zitieren

APA

Jimenez Diaz, V. A., Juan-Salvadores, P., Bellas Lamas, P., Arias Gonzalez, M., Santos Armentia, E., Vila Nieto, O., Gonzalez Mao, C., Torrado Chedas, T., Muñoz Garcia, A. J., Blazquez, I. G., Bastos Fernandez, G., De Miguel Castro, A., Fernandez Barbeira, S., Ortiz Saez, A., Baz Alonso, J. A., Ocampo Miguez, J., Rioboo Leston, L., Pazos Lopez, P., Calvo Iglesias, F., …, & Iñiguez Romo, A. (2025). A comparison of antiplatelet and oral anticoagulation strategies to prevent cerebral microembolism after transcatheter aortic valve implantation: the AUREA trial. EuroIntervention. https://doi.org/10.4244/eij-d-24-00872

Vancouver

Jimenez Diaz VA, Juan-Salvadores P, Bellas Lamas P, Arias Gonzalez M, Santos Armentia E, Vila Nieto O, et al. A comparison of antiplatelet and oral anticoagulation strategies to prevent cerebral microembolism after transcatheter aortic valve implantation: the AUREA trial. EuroIntervention. 2025. doi:10.4244/eij-d-24-00872

BibTeX
@article{JimenezDiaz2025,
  author = {Jimenez Diaz, Victor Alfonso and Juan-Salvadores, Pablo and Bellas Lamas, Paula and Arias Gonzalez, Mercedes and Santos Armentia, Eloisa and Vila Nieto, Oscar and Gonzalez Mao, Carmen and Torrado Chedas, Tamara and Muñoz Garcia, Antonio Jesus and Blazquez, Ivan Gomez and Bastos Fernandez, Guillermo and De Miguel Castro, Antonio and Fernandez Barbeira, Saleta and Ortiz Saez, Alberto and Baz Alonso, Jose Antonio and Ocampo Miguez, Juan and Rioboo Leston, Lucia and Pazos Lopez, Pablo and Calvo Iglesias, Francisco and Salgado Barreira, Angel and Diaz Lopez, Carlos Maria and Figueiras, Adolfo and Veiga Garcia, Cesar and Iñiguez Romo, Andres},
  title = {A comparison of antiplatelet and oral anticoagulation strategies to prevent cerebral microembolism after transcatheter aortic valve implantation: the AUREA trial},
  journal = {EuroIntervention},
  year = {2025},
  doi = {10.4244/eij-d-24-00872}
}
Kostenlos starten →